Effects of intake of nigerooligosaccharides-supplemented syrup on the immune function and quality of life in healthy young adult subjects

Japanese Pharmacology and Therapeutics

Volumn 30, Issue 2, 2002, Pages 81-90

  Murosaki, Shinji ^a   Hirose, Yoshitaka ^a   Yamamoto, Yoshihiro ^a   Ikematsu, Hideyuki ^a   Yukami, Susumu ^a   Nomoto, Kikuo ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Blastogenesis; Immune function; Nigerooligosaccharides; T cells

Indexed keywords

CONCANAVALIN A; CYTOKINE; GAMMA INTERFERON; NIGEROOLIGOSACCHARIDE; NIGEROSE; NIGEROSYLMALTOOLIGOSACCHARIDE; OLIGOSACCHARIDE; PICIBANIL; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIET SUPPLEMENTATION; DRUG EFFECT; FEMALE; HUMAN; HUMAN EXPERIMENT; IMMUNE RESPONSE; LYMPHOCYTE TRANSFORMATION; MALE; MONONUCLEAR CELL; NATURAL KILLER CELL; NORMAL HUMAN; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; SYRUP; T LYMPHOCYTE;

EID: 0036034855     PISSN: 03863603     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Konishi Y, Shindo K. Production of nigerose, nigerosyl glucose, and nigerosyl maltose by Acremonium sp. S4G13. Biosci Biotech Biochem 1997; 61: 439-42.
2. Murosaki S, Muroyama K, Yamamoto Y, Kusaka H, Liu T, Yoshikai Y. Immunopotentiating activity of nigerooligosaccharides for the T helper l-like immune response in mice. Biosci Biotech Biochem 1999; 63: 373-8.
3. Trinchieri G. Interleukin-12 and its role in the generation of TH1 cells. Immunol Today 1993; 14: 335-8.
4. Gajewski TF, Schell SR, Nau G, Fitch FW. Regulation of T-cell activation differences among T-cell subsets. Immunol Rev 1989; 111: 79-110.
5. De Cock W, De Cree J, Van Wauwe J, Verhaegen H. Measurement of mitogen stimulation of lymphocytes with a glucose consumption test. J Immunol Methods 1980; 33: 127-31.
6. Lichtenfels R, Biddison WE, Schulz H, Vogt AB, Martin R. CARE-LASS (calcein-release-assay), an improved fluorescence-based test system to measure cytotoxic T lymphocyte activity. J Immunol Methods 1994; 172: 227-39.
7. Schipper H. Quality of Life. 1990; 17: 716-25.
8. Morimoto K, Takeshita T, Inoue-Sakurai C, Maruyama S. Lifestyles and mental health status are associated with natural killer cell and lymphokine-activated killer cell activities. Sci Total Environ 2001; 270: 3-11.
9. Skoner DP, Whiteside TL, Wilson JW, Doyle WJ, Herberman RB, Fireman P. Effect of influenza A virus infection on natural and adaptive cellular immunity. Clin Immunol Immunopathol 1996; 79: 294-302.
10. Fawaz LM, Sharif-Askari E, Menezes J. Up-regulation of NK cytotoxic activity via IL-15 induction by different viruses: A comparative study. J Immunol 1999; 163: 473-80.
11. Souza SS, Castro FA, Mendonca HC, Palma PV, Morais FR, Ferriani RA, et al. Influence of menstrual cycle on NK activity. J Reprod Immunol 2001; 50 (2): 151-9.
12. Lo KMS, Vivier E, Rochet N, Dehni G, Levine H, Haseltine WA, et al. Infection of human natural killer (NK) cells with replication-defective human T cell leukemia virus type I provirus. Increased proliferative capacity and prolonged survival of functionally competent NK cells. J Immunol 1992; 149: 4101-8.
13. Steingrimsdottir H, Gruber A, Bjorkholm M, Svensson A, Hansson M. Immune reconstitution after autologous hematopoietic stem cell transplantation in relation to underlying disease, type of high-dose therapy and infectious complications. Haematologica 2000; 85: 832-8.
14. Murosaki S, Muroyama K, Yamamoto Y, Liu T, Yoshikai Y. Nigerooligosaccharides augments natural killer activity of hepatic mononuclear cells in mice. Int: Immunopharmacol 2002; 2: 151-9.